Discrepancies in Bone Mineral Density and Fracture Risk in Patients with Type 1 and Type 2 Diabetes--a Meta-analysis

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2006 Oct 28

PMID 17068657

Citations 770

Authors

P Vestergaard

Affiliations

Soon will be listed here.

Abstract

Introduction And Hypothesis: Diabetes affects bone metabolism. The hypothesis was that type 1 (T1D) and type 2 (T2D) affects BMD and fracture risk differently.

Material And Methods: Pubmed, Embase, and Web of Science were searched using the terms "diabetes", "fracture", and "bone mineral".

Results: Hip fracture risk was increased in T1D (RR = 6.94, 95% CI: 3.25-14.78, five studies) and T2D (1.38, 95% CI: 1.25-1.53, eight studies) compared to subjects without diabetes. The increase in relative hip fracture risk was significantly higher in T1D than in T2D. BMD Z-score was decreased in the spine (mean +/- SEM -0.22 +/- 0.01) and hip (-0.37 +/- 0.16) in T1D and increased in the spine (0.41 +/- 0.01) and hip (0.27 +/- 0.01) in T2D. A meta-regression showed that body mass index (BMI) was a major determinant for BMD in both the spine and hip. Glycated haemoglobin (HbA1C) was not linked to BMD. The increase in fracture risk was higher and BMD lower in patients with complications to diabetes.

Conclusions: Hip fracture risk is increased in both T1D and T2D, whereas BMD is increased in T2D and decreased in T1D. A common factor such as complications may explain the increase in fracture risk, whereas BMI may ameliorate the increase in fracture risk in T2D.

Citing Articles

Correlation between diabetes mellitus and refracture risk in patients with osteoporotic fractures: a retrospective cohort study.

Guo S, Xu J, Xu M, Li C, Gong Y, Lu K Aging Clin Exp Res. 2025; 37(1):85.

PMID: 40074983 PMC: 11903520. DOI: 10.1007/s40520-024-02917-1.

Association of Immune-Mediated Inflammatory Diseases and Fracture Risk in Patients with Type 2 Diabetes: A Nationwide Population-Based Study.

Kim Y, Kwon O, Kim R, Kim J, Kim M, Park M J Clin Med. 2025; 14(3).

PMID: 39941466 PMC: 11818108. DOI: 10.3390/jcm14030795.

Mendelian randomization studies of risk and protective factors for osteoporosis: a systematic review and meta-analysis.

Ji W, Pan B, Chen X, Lao Z, Yang W, Qian Y Front Endocrinol (Lausanne). 2025; 15:1486188.

PMID: 39886030 PMC: 11779621. DOI: 10.3389/fendo.2024.1486188.

Association between cardiovascular health and osteoporotic fractures: a national population-based study.

Ou J, Wang T, Lei R, Sun M, Ruan X, Wei J Sci Rep. 2025; 15(1):3844.

PMID: 39885301 PMC: 11782481. DOI: 10.1038/s41598-025-88020-5.

The Influence of Osteoporosis and Diabetes on Dental Implant Stability: A Pilot Study.

Sachelarie L, Scrobota I, Cioara F, Ghitea T, Stefanescu C, Todor L Medicina (Kaunas). 2025; 61(1).

PMID: 39859055 PMC: 11766711. DOI: 10.3390/medicina61010074.

References

van Beresteijn E, van Laarhoven J, Smals A . Body weight and/or endogenous estradiol as determinants of cortical bone mass and bone loss in healthy early postmenopausal women. Acta Endocrinol (Copenh). 1992; 127(3):226-30. DOI: 10.1530/acta.0.1270226. View

Compston J, Smith E, Matthews C, Schofield P . Whole body composition and regional bone mass in women with insulin-dependent diabetes mellitus. Clin Endocrinol (Oxf). 1994; 41(3):289-93. DOI: 10.1111/j.1365-2265.1994.tb02547.x. View

Nicodemus K, Folsom A . Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care. 2001; 24(7):1192-7. DOI: 10.2337/diacare.24.7.1192. View

Chung Y, Lee M, Lee S, Kim H, Fitzpatrick L . HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab. 2000; 85(3):1137-42. DOI: 10.1210/jcem.85.3.6476. View

Kennedy R, Henry J, Chapman A, Nayar R, Grant P, Morris A . Accidents in patients with insulin-treated diabetes: increased risk of low-impact falls but not motor vehicle crashes--a prospective register-based study. J Trauma. 2002; 52(4):660-6. DOI: 10.1097/00005373-200204000-00008. View

Sahin G, Polat G, Bagis S, Milcan A, Erdogan C . Study of axial bone mineral density in postmenopausal women with diffuse idiopathic skeletal hyperostosis related to type 2 diabetes mellitus. J Womens Health (Larchmt). 2003; 11(9):801-4. DOI: 10.1089/15409990260430945. View

Lunt H, Florkowski C, COOK H, Whitehead M . Bone mineral density, type 1 diabetes, and celiac disease. Diabetes Care. 2001; 24(4):791-2. DOI: 10.2337/diacare.24.4.791. View

Lunt M, Masaryk P, Scheidt-Nave C, Nijs J, Poor G, Pols H . The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study. Osteoporos Int. 2001; 12(8):688-98. DOI: 10.1007/s001980170069. View

Vina Simon E, Bueno Lozano G, Armada Maresca M, Ruibal Francisco J, Fernandez Perez C, Lozano Tonkin C . [Bone mineral density in juvenile-onset diabetes mellitus]. An Esp Pediatr. 2000; 52(6):507-15. View

10.

Campos Pastor M, Escobar-Jimenez F, Serrano Pardo M . Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study. Osteoporos Int. 2000; 11(5):455-9. DOI: 10.1007/s001980070114. View

11.

Nabarro J . Compression fractures of the dorsal spine in hypoglycaemic fits in diabetes. Br Med J (Clin Res Ed). 1985; 291(6505):1320. PMC: 1417453. DOI: 10.1136/bmj.291.6505.1320. View

12.

Forsen L, Meyer H, Midthjell K, Edna T . Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey. Diabetologia. 1999; 42(8):920-5. DOI: 10.1007/s001250051248. View

13.

Gerdhem P, Isaksson A, Akesson K, Obrant K . Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int. 2005; 16(12):1506-12. DOI: 10.1007/s00198-005-1877-5. View

14.

Valerio G, Del Puente A, Esposito-del Puente A, Buono P, Mozzillo E, Franzese A . The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res. 2002; 58(6):266-72. DOI: 10.1159/000066441. View

15.

Sert M, Tetiker T, Kirim S, Soyupak S, Canataroglu A, Kocak M . Type 2 diabetes mellitus and osteopenia: is there an association?. Acta Diabetol. 2003; 40(2):105-8. DOI: 10.1007/s005920300014. View

16.

Gunczler P, Lanes R, Paoli M, Martinis R, Villaroel O, Weisinger J . Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2001; 14(5):525-8. DOI: 10.1515/jpem.2001.14.5.525. View

17.

Isaia G, Ardissone P, di Stefano M, Ferrari D, Martina V, Porta M . Bone metabolism in type 2 diabetes mellitus. Acta Diabetol. 1999; 36(1-2):35-8. DOI: 10.1007/s005920050142. View

18.

Rozadilla A, Nolla J, Montana E, Fiter J, Gomez-Vaquero C, Soler J . Bone mineral density in patients with type 1 diabetes mellitus. Joint Bone Spine. 2000; 67(3):215-8. View

19.

Ingberg C, Palmer M, Aman J, Arvidsson B, Schvarcz E, Berne C . Body composition and bone mineral density in long-standing type 1 diabetes. J Intern Med. 2004; 255(3):392-8. DOI: 10.1046/j.1365-2796.2003.01283.x. View

20.

Bouillon R . Diabetic bone disease. Calcif Tissue Int. 1991; 49(3):155-60. DOI: 10.1007/BF02556109. View